Evidence map›Paper›PMID 19754201›Full record

ArticleJournal of medicinal chemistry2009

Physical binding pocket induction for affinity prediction.

James J Langham, Ann E Cleves, Russell Spitzer, Daniel Kirshner, Ajay N Jain

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Predicting drug-target interactions using matrix factorization with self-paced learning and dual similarity information.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  2. Article
  3. Article
  4. Extrapolative prediction using physically-based QSAR.Journal of computer-aided molecular design · 2016
    Article
  5. Article
  6. Article
  7. Does your model weigh the same as a duck?Journal of computer-aided molecular design · 2012
    Article
  8. Article
  9. QMOD: physically meaningful QSAR.Journal of computer-aided molecular design · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

James J LanghamDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California 94158-9001, USA.
Ann E Cleves
Russell Spitzer
Daniel Kirshner
Ajay N Jain
UCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of California, San Francisco · US

Funding

Machine Learning in Chemistry and BiologyR01GM070481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2005 to 2013
$2.5M
Binding-Site Modeling with Multiple-Instance Machine-LearningR01GM101689 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2013 to 2020
$2.4M
NIGMS NIH HHS GM070481NIGMS NIH HHS R01 GM070481NIGMS NIH HHS R01 GM101689
6 · The paper itself

Abstract

Computational methods for predicting ligand affinity where no protein structure is known generally take the form of regression analysis based on molecular features that have only a tangential relationship to a protein/ligand binding event. Such methods have limited utility when structural variation moves beyond congeneric series. We present a novel approach based on the multiple-instance learning method of Compass, where a physical model of a binding site is induced from ligands and their corresponding activity data. The model consists of molecular fragments that can account for multiple positions of literal protein residues. We demonstrate the method on 5HT1a ligands by training on a series with limited scaffold variation and testing on numerous ligands with variant scaffolds. Predictive error was between 0.5 and 1.0 log units (0.7-1.4 kcal/mol), with statistically significant rank correlations. Accurate activity predictions of novel ligands were demonstrated using a validation approach where a small number of ligands of limited structural variation known at a fixed time point were used to make predictions on a blind test set of widely varying molecules, some discovered at a much later time point.

Indexed as

Models, MolecularNeural Networks, ComputerBinding SitesLigandsPeptide FragmentsProtein BindingReceptor, Serotonin, 5-HT1ALigandsPeptide FragmentsReceptor, Serotonin, 5-HT1A

Identifiers

PMID19754201
PMCPMC2766559
OpenAlexW2021461048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.